Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lutein is a dietary xanthophyll carotenoid (C40H56O2) synthesized only by plants, accumulating naturally in foods such as spinach, kale, and egg yolks[5][3][2]. In plants, it modulates light energy and helps protect against photodamage during photosynthesis[5]. In humans, dietary lutein is absorbed preferentially into the macula lutea, where it may serve antioxidant and photoprotective functions, though its precise biological role in the retina remains unknown[5][3]. Lutein is isomeric with zeaxanthin, differing only in the placement of one double bond, and is chemically unstable to light and acid. It is widely used as a food colorant and as a supplement for supporting eye health, particularly in relation to age-related macular degeneration. Lutein is not a canonical drug target, receptor, or enzyme, but is itself a bioactive dietary molecule[3][5].
Lutein acts as an antioxidant and photoprotectant, not as a receptor or enzymatic target[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lutein.